However, strategies that combine both targets, the hydrophobic pocket and the p53-binding cleft of E6 protein, could result in an effective way to disrupt the E6/E6AP/p53 complex to specifically affect the viability of HPV-positive cancer cell lines and proposing specific anti-HPV therapies. Here, TP53 is linked to cancer.